Schizophrenia Research

Papers
(The H4-Index of Schizophrenia Research is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Elevated triglycerides and low triiodothyronine: Key risk factors for coronary artery calcification in patients with schizophrenia176
Exploring associations between trait symptoms and speech patterns in schizophrenia spectrum disorders: A mediation analysis103
Reply to Dyadic interaction in schizophrenia – A promising new avenue of investigation?99
Construction of extra-large scale screening tools for risks of severe mental illnesses using real world healthcare data92
Trends in socioeconomic inequalities in incidence of severe mental illness – A population-based linkage study using primary and secondary care routinely collected data between 2000 and 201769
Meta-analysis of a family history of diabetes in schizophrenia66
A profile of high scores on the Peters delusion inventory and low engagement in pandemic-related health behaviors in a non-clinical sample51
Comorbid psychosis in temporal lobe epilepsy is associated with auditory emotion recognition impairments49
Comments on the manuscript: Arthur Schopenhauer: An underappreciated philosopher in psychiatry and his applied epistemology of body and self-experience44
Alterations in fatty acid metabolism in patients with schizophrenia in a multi-omics perspective44
Frequency of clinical appointments in subjects with emergent suicidal ideation44
Can clozapine be used for treatment-refractory behavioral and psychological symptoms in dementia patients?42
Rethinking psychosis: Time to retire “organic”, “idiopathic” and “secondary”?42
Issue Highlights40
Increased likelihood of distressing and functionally impairing psychotic-like experiences among children with co-occurring internalising and externalising problems40
The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: A population-based cohort study38
The potential of AI for scale development: A self-report psychosis symptoms measure using ChatGPT37
Exploring peripheral biomarkers of response to simvastatin supplementation in schizophrenia37
Denial of anosognosia in schizophrenia37
Hippocampus in the symptom architecture of schizophrenia spectrum disorders: A network analysis approach36
The impact of daily social support on the associations between daily negative events and daily suspiciousness across different clinical stages of psychosis35
Association between negative symptoms and health-related quality of life and functional outcomes in persons with schizophrenia: A systematic review35
Measurement invariance of the Revised-Green Paranoid Thought Scale across Black and White Americans34
Effect of add-on tDCS therapy for auditory hallucinations on frequency and duration deviant mismatch negativity in schizophrenia32
Polygenic risk score of glycemic homeostasis, Type 2 Diabetes Mellitus and glycemic components in first episode psychosis32
Recovery from leukopenia after discontinuation of clozapine does not exclude lymphoma31
A 20-year review comparing the use of ‘schizophrenia’ and ‘psychosis’ in UK newspapers from 2000 to 2019: Implications for stigma reduction31
App for independence: A feasibility randomized controlled trial of a digital health tool for schizophrenia spectrum disorders31
Automated linguistic analysis in speech samples of Turkish-speaking patients with schizophrenia-spectrum disorders31
Substance use and self-poisoning in schizophrenia: 11-year findings from a national clinical survey of suicide in mental health patients in the UK31
Human endogenous retroviruses type W (HERV-) activation and schizophrenia: A meta-analysis31
0.23364305496216